Otonomy to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update

Back to Jobs

SAN DIEGO , Feb. 04, 2021 (GLOBE NEWSWIRE) — Otonomy , Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced it will report financial results for the fourth quarter and full year 2020 and provide a corporate update

Apply Now